ASX - By Stock
|
RCE |
Re:
Ann: Cohort Dosing Complete Ph I/II UTI/Urosepsis Clinical Trial
|
|
Werble
|
41 |
9.3K |
1 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
41
|
9.3K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Cohort Dosing Complete Ph I/II UTI/Urosepsis Clinical Trial
|
|
Werble
|
41 |
9.3K |
1 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
41
|
9.3K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
Werble
|
1.5K |
544K |
3 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
1.5K
|
544K
|
3
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
Werble
|
527 |
251K |
3 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
527
|
251K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
Werble
|
1.5K |
544K |
2 |
16/03/24 |
16/03/24 |
ASX - By Stock
|
1.5K
|
544K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Cohort Dosing Complete Ph I/II UTI/Urosepsis Clinical Trial
|
|
Werble
|
41 |
9.3K |
6 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
41
|
9.3K
|
6
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Cohort Dosing Complete Ph I/II UTI/Urosepsis Clinical Trial
|
|
Werble
|
41 |
9.3K |
2 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
41
|
9.3K
|
2
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
Werble
|
300 |
74K |
6 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
300
|
74K
|
6
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Next Cohort Dosing Ph I/II UTI/Urosepsis Clinical Trial
|
|
Werble
|
39 |
7.2K |
2 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
39
|
7.2K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Next Cohort Dosing Ph I/II UTI/Urosepsis Clinical Trial
|
|
Werble
|
39 |
7.2K |
5 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
39
|
7.2K
|
5
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Next Cohort Dosing Ph I/II UTI/Urosepsis Clinical Trial
|
|
Werble
|
39 |
7.2K |
0 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
39
|
7.2K
|
0
|
|
ASX - By Stock
|
RCE |
Re:
[INTERVIEW] Recce Pharmaceuticals secures AUD$11.18M from Endpoints Capital
|
|
Werble
|
3 |
696 |
4 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
3
|
696
|
4
|
|
ASX - By Stock
|
1AD |
Re:
Ann: Corporate Presentation
|
|
Werble
|
118 |
20K |
1 |
10/03/24 |
10/03/24 |
ASX - By Stock
|
118
|
20K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Dimerix (ASX: DXB) Discussion Thread
|
|
Werble
|
536 |
163K |
16 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
536
|
163K
|
16
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Continues Strategic Partnership with MCRI
|
|
Werble
|
53 |
12K |
1 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
53
|
12K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Continues Strategic Partnership with MCRI
|
|
Werble
|
53 |
12K |
3 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
53
|
12K
|
3
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Continues Strategic Partnership with MCRI
|
|
Werble
|
53 |
12K |
4 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
53
|
12K
|
4
|
|
ASX - By Stock
|
DXB |
Re:
DXB Chart
|
|
Werble
|
752 |
253K |
4 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
752
|
253K
|
4
|
|
ASX - By Stock
|
CHM |
Re:
Chimeric: Media Thread
|
|
Werble
|
658 |
258K |
3 |
02/03/24 |
02/03/24 |
ASX - By Stock
|
658
|
258K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Chimeric to present at ********* Hidden Gems webinar
|
|
Werble
|
17 |
5.2K |
8 |
02/03/24 |
02/03/24 |
ASX - By Stock
|
17
|
5.2K
|
8
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Chimeric to present at ********* Hidden Gems webinar
|
|
Werble
|
17 |
5.2K |
6 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
17
|
5.2K
|
6
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Continues Strategic Partnership with MCRI
|
|
Werble
|
53 |
12K |
7 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
53
|
12K
|
7
|
|
ASX - By Stock
|
TLX |
Re:
Ann: 2023 Full Year Results Presentation
|
|
Werble
|
30 |
10K |
4 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
30
|
10K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix 2023 Full Year Results and Investor Webcast/Call
|
|
Werble
|
130 |
41K |
1 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
130
|
41K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix 2023 Full Year Results and Investor Webcast/Call
|
|
Werble
|
130 |
41K |
3 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
130
|
41K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix 2023 Full Year Results and Investor Webcast/Call
|
|
Werble
|
130 |
41K |
4 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
130
|
41K
|
4
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Application for quotation of securities - DXB
|
|
Werble
|
34 |
9.8K |
4 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
34
|
9.8K
|
4
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Werble
|
34 |
10K |
1 |
02/02/24 |
02/02/24 |
ASX - By Stock
|
34
|
10K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
Werble
|
1.5K |
544K |
3 |
02/02/24 |
02/02/24 |
ASX - By Stock
|
1.5K
|
544K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
AFR - Why $3b Aussie darling Telix needs to grow wings
|
|
Werble
|
17 |
8.5K |
6 |
10/01/24 |
10/01/24 |
ASX - By Stock
|
17
|
8.5K
|
6
|
|
ASX - By Stock
|
TLX |
Re:
AFR - Why $3b Aussie darling Telix needs to grow wings
|
|
Werble
|
17 |
8.5K |
1 |
10/01/24 |
10/01/24 |
ASX - By Stock
|
17
|
8.5K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Plans U.S. Registered Public Offering and Listing
|
|
Werble
|
45 |
17K |
3 |
06/01/24 |
06/01/24 |
ASX - By Stock
|
45
|
17K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
Werble
|
1.5K |
544K |
1 |
21/12/23 |
21/12/23 |
ASX - By Stock
|
1.5K
|
544K
|
1
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
Werble
|
527 |
251K |
5 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
527
|
251K
|
5
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Submits BLA for TLX250-CDx for Kidney Cancer Imaging
|
|
Werble
|
44 |
13K |
2 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
44
|
13K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Update on Financial Reporting Requirements
|
|
Werble
|
14 |
4.0K |
3 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
14
|
4.0K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Update on Financial Reporting Requirements
|
|
Werble
|
14 |
4.0K |
2 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
14
|
4.0K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Update on Financial Reporting Requirements
|
|
Werble
|
14 |
4.0K |
2 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
14
|
4.0K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
Werble
|
1.5K |
544K |
6 |
15/12/23 |
15/12/23 |
ASX - By Stock
|
1.5K
|
544K
|
6
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
Werble
|
1.5K |
544K |
5 |
11/12/23 |
11/12/23 |
ASX - By Stock
|
1.5K
|
544K
|
5
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
Werble
|
527 |
251K |
4 |
06/12/23 |
06/12/23 |
ASX - By Stock
|
527
|
251K
|
4
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
Werble
|
527 |
251K |
6 |
02/12/23 |
02/12/23 |
ASX - By Stock
|
527
|
251K
|
6
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
Werble
|
527 |
251K |
2 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
527
|
251K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
CB presenting at Jefferies London this Thursday (3am)
|
|
Werble
|
17 |
5.0K |
2 |
17/11/23 |
17/11/23 |
ASX - By Stock
|
17
|
5.0K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
CB presenting at Jefferies London this Thursday (3am)
|
|
Werble
|
17 |
5.0K |
3 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
17
|
5.0K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
CB presenting at Jefferies London this Thursday (3am)
|
|
Werble
|
17 |
5.0K |
9 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
17
|
5.0K
|
9
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Announces Proposed Acquisition of QSAM Biosciences
|
|
Werble
|
24 |
8.6K |
6 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
24
|
8.6K
|
6
|
|
ASX - By Stock
|
TLX |
CB presenting at Jefferies London this Thursday (3am)
|
|
Werble
|
17 |
5.0K |
2 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
17
|
5.0K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
Werble
|
1.5K |
544K |
1 |
13/11/23 |
13/11/23 |
ASX - By Stock
|
1.5K
|
544K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Q3 2023 Business Update to Accompany Quarterly Results
|
|
Werble
|
138 |
52K |
5 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
138
|
52K
|
5
|
|